Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ironwood Pharmaceuti (NQ: IRWD ) 4.325 -0.125 (-2.81%) Streaming Delayed Price Updated: 1:56 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Ironwood Pharmaceuti < Previous 1 2 3 Next > Ironwood Pharmaceuticals to Host Third Quarter 2021 Investor Update Call October 21, 2021 From Ironwood Pharmaceuticals, Inc. Via Business Wire Ironwood Pharmaceuticals to Participate in Upcoming September Investor Conferences September 02, 2021 From Ironwood Pharmaceuticals, Inc. Via Business Wire Ironwood Pharmaceuticals Announces FDA Approval of Revised LINZESS® (linaclotide) Label August 26, 2021 From Ironwood Pharmaceuticals, Inc. Via Business Wire Ironwood Pharmaceuticals Reports Strong Second-Quarter 2021 Results, Raises Full-Year Guidance August 05, 2021 From Ironwood Pharmaceuticals, Inc. Via Business Wire Ironwood Pharmaceuticals Appoints John Minardo as Chief Legal Officer August 03, 2021 From Ironwood Pharmaceuticals, Inc. Via Business Wire Ironwood Pharmaceuticals to Host Second Quarter 2021 Investor Update Call July 22, 2021 From Ironwood Pharmaceuticals, Inc. Via Business Wire Ironwood Pharmaceuticals Announces That The American Journal of Gastroenterology Publishes Full Results from Positive LINZESS® (linaclotide) Phase IIIb Trial in Adults with Irritable Bowel Syndrome with Constipation (IBS-C) June 16, 2021 From Ironwood Pharmaceuticals, Inc. Via Business Wire Ironwood Pharmaceuticals Announces Leadership Updates June 07, 2021 From Ironwood Pharmaceuticals, Inc. Via Business Wire Ironwood Pharmaceuticals Announces Agreement with Teva Involving LINZESS® (linaclotide) 72 mcg Dosage Strength May 26, 2021 From Ironwood Pharmaceuticals, Inc. Via Business Wire More Than a Third of Surveyed IBS-C Patients Reported That Their Symptoms Worsened During COVID-19 According to New Survey Findings Presented by Ironwood Pharmaceuticals at Digestive Disease Week® (DDW) May 24, 2021 From Ironwood Pharmaceuticals, Inc. Via Business Wire Ironwood Pharmaceuticals to Present New Linaclotide Data and Unveil Findings From GI Disease Surveys at Digestive Disease Week® 2021 May 17, 2021 From Ironwood Pharmaceuticals, Inc. Via Business Wire Ironwood Pharmaceuticals Announces New $150 Million Share Repurchase Program May 06, 2021 From Ironwood Pharmaceuticals, Inc. Via Business Wire Ironwood Pharmaceuticals Reports First Quarter 2021 Results May 06, 2021 From Ironwood Pharmaceuticals, Inc. Via Business Wire Ironwood Pharmaceuticals to Host First Quarter 2021 Investor Update Call April 22, 2021 From Ironwood Pharmaceuticals, Inc. Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.